Cancer Research Cancer Health Disparities Conference 2009  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 2574-2581, July 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evenson, D. P.
Right arrow Articles by Melamed, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evenson, D. P.
Right arrow Articles by Melamed, M. R.

Effects of 9,10-Anthracenedione, 1,4-Bis{{2-{(2-hydroxyethyl)amino}-ethyl}amino}-diacetate on Cell Survival and Cell Cycle Progression in Cultured Mammalian Cells1

Donald P. Evenson2, Zbigniew Darzynkiewicz, Lisa Staiano-Coico, Frank Traganos and Myron R. Melamed

Memorial Sloan-Kettering Cancer Center, New York, New York 10021

9,10-Anthracenedione, 1,4-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-diacetate (NSC 287513), at concentrations ranging from 0.05 to 10.0 µg/ml, altered the cell cycle kinetics of Chinese hamster, Friend leukemia, and SK-L7 cells cultivated in vitro; the drug had little effect on cycle progression of normal phytohemagglutinin-stimulated lymphocytes. The major effect, following a 2- to 18-hr exposure to drug, was a block of cell cycle progression at the G2-M phases as determined by flow cytometry. Although the mode of blocking action was concentration dependent, the results were similar for both a 2- and 18-hr drug treatment. Blocked cells typically had an increased amount of cellular RNA and in some cases abnormally large nucleoli. The terminal point of action in Friend leukemia cells occurred about 3 hr prior to mitosis, or within the last quarter of S phase. Unique to Friend leukemia cells was the observation that after drug treatment, at concentrations of 0.05 to 0.2 µg/ml for 2 to 18 hr followed by cell transfer to normal media, approximately 30% of the cells entered the cycle at a higher ploidy level.

Survival curves on treated log phase Chinese hamster cells indicated that the cell kill response was straight line exponential; 50% survival (measured by colony formation) occurred following a 2-hr treatment at 0.7 µg/ml. Stationary-phase-treated Chinese hamster cells were much more resistant to the drug action; 50% survival was observed following a 2-hr treatment at 10 µg/ml. The data suggest that, although the drug-induced cycle block is specific to the G2 phase, the drug-induced kill is not cycle phase specific.

1 Supported by Grant CA23296-01 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, N. Y. 10021.

Received 1/26/79. Accepted 4/ 4/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.